insights_auto
Why is ALLO down 5.88%?
Dive Deeperchevron_right
ALLO:NASDAQ
Allogene Therapeutics Inc
$0.63
arrow_downward
-5.88%(-0.039) 1D
$0.63
arrow_upward
+1.12% (+0.0070)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALLO...
Open
$0.64
High
$0.67
Low
$0.62
Mkt. cap
217.48M
Avg. vol.
10.12M
Volume
7.58M
52-wk high
$4.46
52-wk low
$0.62
EPS
-$0.62
Beta
0.76
Shares outstanding
346.47M
No. of employees
150
Open
$0.64
High
$0.67
Low
$0.62
Mkt. cap
217.48M
Avg. vol.
10.12M
Volume
7.58M
52-wk high
$4.46
52-wk low
$0.62
EPS
-$0.62
Beta
0.76
Shares outstanding
346.47M
No. of employees
150
News stories
From web sources and news partners
TradingView
·
3 hours ago
Gold’s Correlation With S&P 500 Climbs to 0.35 as Both Assets Move Together
FOREX.com
·
2 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingKey
·
9 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
3 hours ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteallogene.com